Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

NCT00701688 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Oral Mucositis
Hematopoietic Stem Cell Transplantation

Interventions

DRUG: Palifermin

Sponsor

St. Jude Children's Research Hospital